Branden S Moriarity

7PUBLICATIONS
36CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsTissue engineeringMolecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 24, 2026
CISH, a key intracellular checkpoint, in comparison and combination to existing and emerging cancer immune checkpoints.

Florencia Cano, Alberto Bravo-Blas, Mathilde Colombe

|Dec 03, 2025
NK cell immunotherapy administered at the time of HIV recrudescence is associated with viral control.

Liliana K Thron, Pongthorn Pumtang-On, Jae Woong Chang

|Nov 18, 2024
Ablation of FAS confers allogeneic CD3- CAR T cells with resistance to rejection by T cells and natural killer cells.

Silvia Menegatti, Sheila Lopez-Cobo, Aurelien Sutra Del Galy

|Mar 18, 2024
Precision Enhancement of CAR-NK Cells through Non-Viral Engineering and Highly Multiplexed Base Editing.

Minjing Wang, Joshua B Krueger, Alexandria K Gilkey

Pageof 2